GO:0004052 arachidonate 12(S)-lipoxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004052 describes the enzymatic activity that converts arachidonic acid and oxygen into 12(S)-hydroperoxyeicosatetraenoic acid (12(S)-HPETE), a key step in eicosanoid biosynthesis.
• The enzyme is widely known as 12-lipoxygenase (12-LOX) and is encoded by ALOX12 in humans; its expression is tightly controlled at the transcriptional level by factors such as Sp1 and Hsp90alpha.
• 12(S)-lipoxygenase activity produces lipid mediators that influence platelet function, vascular permeability, and inflammation, making it a candidate target for antiplatelet and anti-inflammatory therapies.
• Dysregulated 12(S)-lipoxygenase activity has been linked to cancer progression, including colorectal cancer, where enzyme overexpression is used to screen for inhibitors.
• The catalytic mechanism involves stereospecific oxygenation of arachidonic acid at carbon 12, yielding the 12(S) hydroperoxide, and the enzyme can also act as a leukotriene A4 synthase in some contexts.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of 12(S)-lipoxygenase function in human disease and drug discovery.
Description
Arachidonate 12(S)-lipoxygenase activity (GO:0004052) is a molecular function that catalyzes the stereospecific oxygenation of arachidonic acid to form (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate, commonly known as 12(S)-HPETE. This reaction represents a committed step in the lipoxygenase pathway of eicosanoid biosynthesis, generating lipid mediators that modulate inflammation, platelet aggregation, and vascular tone. The enzyme responsible, often termed 12-lipoxygenase (12-LOX), is a member of the lipoxygenase family and is encoded by the ALOX12 gene in humans. Because of its central role in producing bioactive lipids, 12(S)-lipoxygenase activity has attracted attention as a therapeutic target in cardiovascular disease, cancer, and inflammatory disorders. Researchers study this activity to understand how lipid signaling contributes to physiology and pathology, and to develop selective inhibitors or genetic models that modulate its function. The availability of CRISPR tools now allows precise editing of ALOX12 and related genes, enabling causal tests of 12(S)-lipoxygenase activity in human cell models.
arachidonate 12(S)-lipoxygenase activity At A Glance
| GO ID | GO:0004052 |
|---|---|
| GO term | arachidonate 12(S)-lipoxygenase activity |
| Ontology | molecular_function |
| Synonym | 12-lipoxygenase activity; 12S-lipoxygenase activity; leukotriene A4 synthase; 12Delta-lipoxygenase activity; arachidonate:oxygen 12-oxidoreductase activity |
| Definition | Catalysis of the reaction: arachidonate + O2 = (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate. |
| Major function | Production of 12(S)-hydroperoxyeicosatetraenoic acid (12(S)-HPETE) from arachidonic acid |
| Cofactors | Non-heme iron (typical for lipoxygenases) |
| Subcellular location | Cytosol and membrane-associated compartments |
| Related genes | ALOX12 (human), Alox12 (mouse), Alox12b, Alox12e |
What Is GO:0004052?
In our own words, GO:0004052 describes the catalytic activity of an enzyme that uses molecular oxygen to oxidize arachidonic acid specifically at carbon 12, producing the 12(S)-hydroperoxy derivative. The reaction is: arachidonate + O2 = (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate. This activity is synonymous with 12-lipoxygenase, 12S-lipoxygenase, and leukotriene A4 synthase, reflecting its ability to generate 12(S)-HPETE and, in some contexts, leukotriene A4.
Why Is arachidonate 12(S)-lipoxygenase activity Important in Cell Biology?
Arachidonate 12(S)-lipoxygenase activity is important because it initiates the synthesis of lipid mediators that regulate platelet activation, vascular permeability, and inflammatory responses. Its product, 12(S)-HPETE, can be further metabolized to hepoxilins and other eicosanoids that influence endothelial barrier function and leukocyte recruitment. Dysregulated 12-lipoxygenase activity has been implicated in colorectal cancer, where enzyme overexpression is used as a cellular model for inhibitor screening. In the cardiovascular system, 12-LOX is considered a potential target for novel antiplatelet therapies, as it contributes to thrombus formation. Understanding this activity at the molecular level is therefore essential for developing selective inhibitors and for interpreting genetic variants that alter eicosanoid profiles.
• Produces 12(S)-HPETE, a precursor to hepoxilins and other bioactive lipids that modulate vascular permeability.
• Plays a role in platelet function and is a candidate target for antiplatelet therapy.
• Overexpression in colorectal cancer cells provides a model for screening 12(S)-lipoxygenase inhibitors.
• Transcriptional regulation by Sp1 and Hsp90alpha highlights integration with cellular stress and signaling pathways.
• The enzyme can exhibit leukotriene A4 synthase activity, linking it to leukotriene biosynthesis.
• Genetic variation in ALOX12 may influence inflammatory and cardiovascular disease risk.
• CRISPR knockout of ALOX12 can clarify its causal role in eicosanoid production and disease phenotypes.
• Point mutations in the catalytic domain can dissect substrate specificity and stereochemistry.
• Knock-in of tagged ALOX12 enables live-cell imaging and interactome studies.
• Overexpression models facilitate high-throughput drug discovery targeting 12-LOX.
What Happens During arachidonate 12(S)-lipoxygenase activity?
Substrate binding and oxygen activation
In simple terms: The enzyme grabs arachidonic acid and oxygen to start the reaction.
The catalytic cycle begins with the binding of arachidonic acid to the enzyme's active site, where a non-heme iron atom is coordinated by conserved histidine residues. Molecular oxygen then reacts with the iron to form a ferric-hydroperoxo intermediate, priming the substrate for stereospecific oxidation.
Stereospecific hydrogen abstraction and oxygenation
In simple terms: The enzyme removes a hydrogen from carbon 12 and adds oxygen in a specific orientation.
The enzyme abstracts a hydrogen atom from carbon 12 of arachidonic acid, generating a radical that reacts with oxygen to form the 12(S)-hydroperoxy product. This step is highly stereospecific, yielding the 12(S) enantiomer rather than the 12(R) form.
Product release and downstream metabolism
In simple terms: The product 12(S)-HPETE is released and can be converted into other signaling lipids.
After formation, 12(S)-HPETE is released from the active site and can be reduced to 12(S)-HETE or further metabolized to hepoxilins. These metabolites act on vascular and inflammatory cells to modulate permeability and platelet function.
Alternative catalytic mode: leukotriene A4 synthase
In simple terms: The same enzyme can sometimes produce leukotriene A4 instead.
In certain contexts, 12(S)-lipoxygenase exhibits leukotriene A4 synthase activity, converting arachidonic acid to leukotriene A4, a key intermediate in leukotriene biosynthesis. This dual activity links the enzyme to both 12-lipoxygenase and leukotriene pathways.
Key Genes Involved in GO:0004052 arachidonate 12(S)-lipoxygenase activity
The following genes and proteins are directly or indirectly associated with arachidonate 12(S)-lipoxygenase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALOX12 | Encodes human 12(S)-lipoxygenase; catalyzes arachidonic acid to 12(S)-HPETE | Target for inhibitor screening and CRISPR knockout in cancer and platelet studies |
| ALOX12B | Encodes 12R-lipoxygenase; related lipoxygenase with distinct stereospecificity | Used to contrast 12(S) vs 12(R) activity in skin and barrier function |
| ALOX12E | Encodes epidermis-type lipoxygenase; may contribute to 12(S)-lipoxygenase activity | Potential redundant activity in epithelial tissues |
| ALOX5 | Encodes 5-lipoxygenase; produces leukotriene A4 | Comparative studies of leukotriene biosynthesis |
| ALOX15 | Encodes 15-lipoxygenase; produces 15(S)-HPETE | Contrasts substrate specificity and stereochemistry |
| SP1 | Transcription factor that binds the ALOX12 promoter | Regulates 12(S)-lipoxygenase expression in response to phorbol esters |
| HSP90AA1 | Chaperone recruited by Sp1 to enhance ALOX12 transcription | Modulates 12(S)-lipoxygenase levels in A431 cells |
| EP300 | Histone acetyltransferase p300; coactivator of ALOX12 transcription | Links chromatin remodeling to 12(S)-lipoxygenase expression |
| PTGS1 | Cyclooxygenase-1; parallel pathway for arachidonic acid metabolism | Comparative eicosanoid studies |
| PTGS2 | Cyclooxygenase-2; inducible pathway in inflammation | Cross-talk with lipoxygenase pathways |
| ALOX12P1 | Pseudogene related to ALOX12 | May regulate ALOX12 expression via RNA interference |
| MAPK1 | Mitogen-activated protein kinase; signaling upstream of ALOX12 | Influences 12(S)-lipoxygenase expression |
| MAPK3 | ERK1; contributes to transcriptional regulation | Modulates ALOX12 promoter activity |
| NFKB1 | Transcription factor in inflammatory signaling | Potential regulator of ALOX12 in inflammation |
| STAT3 | Signal transducer and activator of transcription | May influence ALOX12 expression in cancer |
| TP53 | Tumor suppressor; mutant p53 may alter lipid metabolism | Context-dependent regulation of 12-LOX in cancer |
| VEGFA | Vascular endothelial growth factor; downstream of eicosanoids | Links 12(S)-lipoxygenase to angiogenesis |
| ICAM1 | Adhesion molecule induced by inflammatory lipids | Readout of 12(S)-HPETE activity in endothelium |
How Is arachidonate 12(S)-lipoxygenase activity Regulated?
The expression and activity of arachidonate 12(S)-lipoxygenase are regulated at multiple levels. Transcription of the human ALOX12 gene is controlled by the transcription factor Sp1, which binds to GC-rich elements in the promoter and recruits coactivators such as Hsp90alpha and p300. Phorbol esters and other stimuli can induce Sp1 deacetylation, leading to p300 recruitment and enhanced transcription. In addition, signaling pathways involving MAP kinases and inflammatory transcription factors may modulate ALOX12 expression in response to cytokines and growth factors. At the protein level, the enzyme's activity can be influenced by calcium, membrane association, and post-translational modifications, although these mechanisms are less well defined in the literature. The interplay between transcriptional and signaling regulation determines the levels of 12(S)-HPETE and downstream eicosanoids in different cell types.
arachidonate 12(S)-lipoxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALOX12 | Colorectal cancer | Overexpression in colorectal cancer cell lines for inhibitor screening |
| ALOX12 | Thrombosis and platelet activation | Platelet-specific knockout or point-mutation models |
| ALOX12 | Vascular permeability and inflammation | Endothelial cell knock-in of tagged ALOX12 for imaging |
| ALOX12B | Skin barrier disorders | Keratinocyte knockout models |
| ALOX5 | Asthma and leukotriene-driven inflammation | Comparative knockout in immune cells |
Cancer
Overexpression of 12(S)-lipoxygenase has been observed in colorectal cancer cells, where the enzyme is used as a target for inhibitor screening. The enzyme's product, 12(S)-HPETE, can promote cell proliferation and survival, and its activity may contribute to tumor progression. Targeting 12-LOX with small-molecule inhibitors or CRISPR knockout is being explored as a therapeutic strategy in cancers with elevated enzyme levels.
Cardiovascular disease and thrombosis
12(S)-lipoxygenase activity in platelets contributes to the production of 12(S)-HETE, which amplifies platelet activation and thrombus formation. Targeting 12-LOX has been proposed as a novel antiplatelet therapy, particularly for patients with resistance to conventional antiplatelet drugs. The enzyme's role in vascular permeability further links it to edema and inflammation.
Inflammation and vascular permeability
In vivo studies in rat skin have shown that bradykinin and platelet-activating factor stimulate 12(S)-lipoxygenase, leading to the formation of 12(S)-HETE and hepoxilins that increase vascular permeability. This suggests that 12-LOX inhibitors could reduce edema in inflammatory conditions. The enzyme thus represents a node where lipid signaling intersects with vascular biology.
From arachidonate 12(S)-lipoxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ALOX12 loss reduce 12(S)-HPETE production? | CRISPR knockout of ALOX12 in human cell lines |
| Which residues determine stereospecificity? | Point mutations in the catalytic domain of ALOX12 |
| Can a disease-associated variant alter enzyme activity? | Knock-in of the variant into the endogenous ALOX12 locus |
| Where is the enzyme localized in live cells? | Knock-in of a fluorescent tag (e.g., GFP) at the ALOX12 locus |
| Does overexpression drive tumor phenotypes? | Stable overexpression of ALOX12 in cancer cell lines |
| Can 12-LOX inhibitors be screened efficiently? | Overexpression of ALOX12 in colorectal cancer cells for high-throughput assays |
How to Study the arachidonate 12(S)-lipoxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC/LC-MS | 12(S)-HPETE and 12(S)-HETE levels | Enzyme activity in cell lysates |
| RT-qPCR | ALOX12 mRNA expression | Transcriptional regulation studies |
| Western blot | 12-LOX protein levels | Overexpression and knockout validation |
| ChIP | Sp1 binding to ALOX12 promoter | Transcriptional mechanism |
| Immunofluorescence | Subcellular localization of tagged 12-LOX | Knock-in imaging |
| Lipidomics | Global eicosanoid profile | Pathway analysis |
| Platelet aggregation assay | Functional impact of 12-LOX inhibition | Anti platelet drug discovery |
| CRISPR screening | Genes modifying 12-LOX activity | Library screening |
Enzymatic activity assays
Direct measurement of 12(S)-lipoxygenase activity can be performed using cell lysates or purified enzyme with arachidonic acid as substrate, followed by detection of 12(S)-HPETE by HPLC or LC-MS. Overexpression of the enzyme in colorectal cancer cells provides a robust system for inhibitor screening.
Gene expression analysis
Transcript levels of ALOX12 can be quantified by RT-qPCR or RNA-seq. The promoter's regulation by Sp1 and Hsp90alpha can be studied using reporter assays and chromatin immunoprecipitation.
Protein interaction and localization
Tagged knock-in of ALOX12 enables immunofluorescence and live-cell imaging to determine subcellular localization. Co-immunoprecipitation and proximity labeling can identify interacting proteins such as Sp1 and Hsp90alpha.
Lipidomics and metabolomics
Mass spectrometry-based lipidomics can profile 12(S)-HPETE, 12(S)-HETE, hepoxilins, and other eicosanoids in cells and tissues. This approach is useful for assessing the impact of CRISPR edits on the entire lipid network.
How CRISPR Can Be Used to Study GO:0004052 arachidonate 12(S)-lipoxygenase activity
Knockout
CRISPR knockout of ALOX12 in human cell lines, such as colorectal cancer cells, can abolish 12(S)-lipoxygenase activity and reduce 12(S)-HPETE production. This model is useful for confirming the enzyme's role in eicosanoid biosynthesis and for testing compensatory pathways.
Point Mutation
Introducing point mutations in the catalytic domain of ALOX12 can dissect the residues required for iron coordination and stereospecific oxygenation. Such mutants help distinguish 12(S)-lipoxygenase activity from related lipoxygenases.
Knock-in
Knock-in of a fluorescent tag or a disease-associated variant at the endogenous ALOX12 locus allows real-time imaging and functional analysis under native regulatory control. This approach is valuable for studying transcriptional regulation by Sp1 and Hsp90alpha.
Overexpression
Stable overexpression of ALOX12 in cancer cell lines, such as colorectal cancer cells, provides a sensitive system for screening 12(S)-lipoxygenase inhibitors and for studying downstream signaling.
How EDITGENE Supports arachidonate 12(S)-lipoxygenase activity Research
Researchers studying arachidonate 12(S)-lipoxygenase activity-related genes often need to determine whether a candidate gene is causally involved in eicosanoid production, platelet function, or cancer phenotypes. EDITGENE provides a suite of CRISPR-based services to generate precisely edited cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for arachidonate 12(S)-lipoxygenase activity research.
Frequently Asked Questions About arachidonate 12(S)-lipoxygenase activity
What is arachidonate 12(S)-lipoxygenase activity?
It is the enzymatic activity (GO:0004052) that converts arachidonic acid and oxygen into 12(S)-hydroperoxyeicosatetraenoic acid (12(S)-HPETE), a key step in eicosanoid biosynthesis.
What genes are involved in arachidonate 12(S)-lipoxygenase activity?
The primary gene is ALOX12, which encodes the human 12(S)-lipoxygenase enzyme. Related genes include ALOX12B, ALOX12E, and ALOX5.
What is the reaction catalyzed by GO:0004052?
The reaction is: arachidonate + O2 = (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate, producing 12(S)-HPETE.
How is 12(S)-lipoxygenase activity regulated?
It is regulated transcriptionally by Sp1, Hsp90alpha, and p300, and can be influenced by signaling pathways involving MAP kinases.
What diseases are associated with 12(S)-lipoxygenase activity?
It has been linked to colorectal cancer, thrombosis, and inflammatory conditions involving vascular permeability.
Can CRISPR be used to study 12(S)-lipoxygenase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of ALOX12 function in human cells.
What is the role of 12(S)-HPETE?
12(S)-HPETE is a lipid mediator that can be reduced to 12(S)-HETE or converted to hepoxilins, influencing platelet function and vascular permeability.
Is 12(S)-lipoxygenase the same as leukotriene A4 synthase?
Leukotriene A4 synthase is a synonym for the same activity, reflecting the enzyme's ability to produce leukotriene A4 in some contexts.
How can I measure 12(S)-lipoxygenase activity in the lab?
Common methods include HPLC or LC-MS detection of 12(S)-HPETE, RT-qPCR for ALOX12 mRNA, and Western blot for protein levels.
What cell models are available for 12(S)-lipoxygenase research?
Colorectal cancer cells overexpressing the enzyme are widely used for inhibitor screening, and CRISPR-edited lines provide causal models.
Conclusion
Arachidonate 12(S)-lipoxygenase activity (GO:0004052) is a central enzymatic function in eicosanoid biology, producing 12(S)-HPETE and related lipid mediators that influence inflammation, platelet function, and cancer. Its regulation by Sp1, Hsp90alpha, and p300 highlights the integration of transcriptional control with cellular signaling. The availability of CRISPR-based models now enables researchers to move from correlation to causation, testing the role of ALOX12 and its variants in human disease. Continued study of this activity promises to yield new therapeutic strategies for thrombosis, inflammation, and cancer.
References
- 1. Bednar W et al.. 2007. Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme.. Food Chem Toxicol 45(3):508-14 PMID: 17027136
- 2. Coffa G et al.. 2000. Discovery of an 11 (R)- and 12(S)-lipoxygenase activity in ovaries of the mussel Mytilus edulis.. Lipids 35(11):1195-204 PMID: 11132179
- 3. Chang WC. 2003. Cell signaling and gene regulation of human 12(S)-lipoxygenase expression.. Prostaglandins Other Lipid Mediat 71(3-4):277-85 PMID: 14518567
- 4. Tourdot BE et al.. 2017. Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy.. Trends Pharmacol Sci 38(11):1006-1015 PMID: 28863985
- 5. Chang WC et al.. 2005. Transcription factor Sp1 functions as an anchor protein in gene transcription of human 12(S)-lipoxygenase.. Biochem Biophys Res Commun 338(1):117-21 PMID: 16122700
- 6. Hung JJ et al.. 2005. Hsp90alpha recruited by Sp1 is important for transcription of 12(S)-lipoxygenase in A431 cells.. J Biol Chem 280(43):36283-92 PMID: 16118214
- 7. Wang MM et al.. 1999. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability.. Biochim Biophys Acta 1436(3):354-62 PMID: 9989266
- 8. Hung JJ et al.. 2006. Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription.. Mol Cell Biol 26(5):1770-85 PMID: 16478997
